Mazor Robotics (MZOR) vs. Danaher (DHR) Head-To-Head Survey

Mazor Robotics (NASDAQ: MZOR) and Danaher (NYSE:DHR) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, analyst recommendations, earnings, institutional ownership and profitability.

Valuation and Earnings

This table compares Mazor Robotics and Danaher’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Mazor Robotics $36.38 million 37.89 -$18.66 million ($0.71) -76.08
Danaher $16.88 billion 3.85 $2.55 billion $3.36 27.82

Danaher has higher revenue and earnings than Mazor Robotics. Mazor Robotics is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Mazor Robotics has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Comparatively, Danaher has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500.


Danaher pays an annual dividend of $0.56 per share and has a dividend yield of 0.6%. Mazor Robotics does not pay a dividend. Danaher pays out 16.7% of its earnings in the form of a dividend. Mazor Robotics has raised its dividend for 3 consecutive years.


This table compares Mazor Robotics and Danaher’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Mazor Robotics -28.80% -22.68% -18.29%
Danaher 13.36% 11.29% 6.01%

Analyst Ratings

This is a summary of current ratings and recommmendations for Mazor Robotics and Danaher, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mazor Robotics 2 5 1 0 1.88
Danaher 0 5 10 0 2.67

Mazor Robotics presently has a consensus price target of $39.60, suggesting a potential downside of 26.69%. Danaher has a consensus price target of $94.19, suggesting a potential upside of 0.78%. Given Danaher’s stronger consensus rating and higher possible upside, analysts plainly believe Danaher is more favorable than Mazor Robotics.

Insider and Institutional Ownership

26.4% of Mazor Robotics shares are owned by institutional investors. Comparatively, 76.1% of Danaher shares are owned by institutional investors. 12.2% of Danaher shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.


Danaher beats Mazor Robotics on 14 of the 17 factors compared between the two stocks.

About Mazor Robotics

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications. Its Renaissance System and its predecessor are used in a number of spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision and cement augmentations. Furthermore the Company developed the Renaissance Brain Module, an application of its Renaissance System that provides control over the insertion of surgical instruments during brain surgery.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. As of December 31, 2016, Danaher’s research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.

Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit